financetom
Business
financetom
/
Business
/
United Airlines Swaps Boeing Max 10 for Max 9 Jets, Mulls Airbus Order
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Airlines Swaps Boeing Max 10 for Max 9 Jets, Mulls Airbus Order
Mar 12, 2024 8:56 AM

11:20 AM EDT, 03/12/2024 (MT Newswires) -- United Airlines (UAL) has asked Boeing ( BA ) to start building Max 9 jets instead of Max 10s while waiting for the Max 10 to get certified, Chief Executive Scott Kirby said at a JPMorgan investor conference Tuesday.

United will opt back to the Max 10 after the plane gets certified, although "it's impossible to say" when a certification would be issued, Kirby said, according to a Capital IQ transcript of the interview.

"If and when the Max 10 gets certified, we'll convert them back to -- we'll convert forward-looking to Max 10s. But Max 10 is out for us until it's certified," Kirby was quoted in the transcript.

The company is considering replacing part of its order for 277 Max 10s with A321s, Kirby also said.

"We are in the market, we've been pretty public in the market, for A321s. And if we get a deal that the economics work, then we'll do something," he said.

Boeing ( BA ) did not immediately respond to MT Newswires' request for comment.

Price: 41.90, Change: -0.99, Percent Change: -2.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
May 31, 2024
May 31 (Reuters) - Sanofi and partner Regeneron Pharmaceuticals ( REGN ) have secured the European regulator's backing for use of Dupixent in patients with a chronic lung disease even as the U.S. Food and Drug Administration (FDA) extended its review. French drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as an...
Aimia Files Information Circular With Proposed Director Nominees Ahead of Shareholders' Meeting
Aimia Files Information Circular With Proposed Director Nominees Ahead of Shareholders' Meeting
May 31, 2024
07:47 AM EDT, 05/31/2024 (MT Newswires) -- Aimia ( AIMFF ) , which is battling with its largest shareholder Mithaq Capital to maintain control of its board, has filed its management information circular and slate of director nominees with Canadian regulatory authorities ahead of its annual shareholders' meeting on June 26. Yesterday, Mithaq proposed a slate of six nominees to...
Prospera Energy Swings to Q1 Operating Profit as Revenue Rises and Operating Costs Decline
Prospera Energy Swings to Q1 Operating Profit as Revenue Rises and Operating Costs Decline
May 31, 2024
07:44 AM EDT, 05/31/2024 (MT Newswires) -- Prospera Energy ( GXRFF ) on Friday reported that it swung to an operating profit in the first-quarter as revenue rose and operating costs declined. The company booked an operating profit of $559,907, improving from a loss of $995,840. Sales revenue jumped 168% to $4.2 million on the back of increased production and...
Clarivate Partners With HealthWise Data to Enhance Patient Insights
Clarivate Partners With HealthWise Data to Enhance Patient Insights
May 31, 2024
07:42 AM EDT, 05/31/2024 (MT Newswires) -- Clarivate ( CLVT ) said Friday it has partnered with HealthWise Data to enhance insights into patient demographics and behavior. The collaboration integrates Healthwise's social determinants of health into Clarivate's ( CLVT ) real-world data repository, providing comprehensive insights into a patient's income, education, ethnicity and other non-medical factors to help healthcare and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved